acetylcysteine has been researched along with Cortical Lewy Body Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bajic, N; Ballard, CG; Francis, PT; Jenner, P | 1 |
Jenner, P; McNaught, KS; Olanow, CW; Perl, DP; Shashidharan, P | 1 |
Ballard, C; Iravani, MM; Jenner, P; MacInnes, N; Perry, E; Perry, R; Piggott, M | 1 |
Hashimoto, M; Hsu, LJ; Masliah, E; Takeda, A; Takenouchi, T | 1 |
Larsen, KE; Rideout, HJ; Stefanis, L; Sulzer, D | 1 |
5 other study(ies) available for acetylcysteine and Cortical Lewy Body Disease
Article | Year |
---|---|
Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture.
Topics: Acetylcysteine; alpha-Synuclein; Animals; Blotting, Western; Cells, Cultured; Cysteine Proteinase Inhibitors; Immunohistochemistry; Lewy Body Disease; Neurons; Neuropeptides; Oligopeptides; Proteasome Endopeptidase Complex; Rats; Rats, Wistar; Synapses; Synaptophysin; Tubulin; Ubiquitination | 2012 |
Aggresome-related biogenesis of Lewy bodies.
Topics: Acetylcysteine; Antigens; Brain; Canavanine; Centrosome; Dose-Response Relationship, Drug; Golgi Apparatus; HSP70 Heat-Shock Proteins; Humans; Immunohistochemistry; Lewy Bodies; Lewy Body Disease; Nerve Tissue Proteins; Neurons; Parkinson Disease; Peptide Hydrolases; Protein Folding; Synucleins; Tubulin; Ubiquitins | 2002 |
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
Topics: Acetylcholine; Acetylcysteine; Aged; Aged, 80 and over; alpha-Synuclein; Animals; Basal Nucleus of Meynert; Cell Death; Cells, Cultured; Cerebral Cortex; Cholinergic Fibers; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Lewy Bodies; Lewy Body Disease; Male; Nerve Degeneration; Nerve Tissue Proteins; Neural Pathways; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Rats, Sprague-Dawley; Ubiquitin | 2008 |
Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease.
Topics: Acetylcysteine; alpha-Synuclein; Antioxidants; Brain; Cytochrome c Group; Deferoxamine; Humans; Hydrogen Peroxide; Immunohistochemistry; Lewy Body Disease; Nerve Tissue Proteins; Oxidative Stress; Recombinant Proteins; Synucleins | 1999 |
Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
Topics: Acetylcysteine; alpha-Synuclein; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Cell Differentiation; Cyclic AMP; Cysteine Endopeptidases; Immunoblotting; Immunohistochemistry; Inclusion Bodies; Lewy Body Disease; Multienzyme Complexes; Nerve Tissue Proteins; Neuroprotective Agents; Oligopeptides; Parkinson Disease; PC12 Cells; Protease Inhibitors; Proteasome Endopeptidase Complex; Rats; Synucleins; Ubiquitins | 2001 |